why choose us

First received: October 05, 2022

Clinical Trial: Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ulcerative Colitis

Study Type: INTERVENTIONAL


Official Title: A Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of ABBV-668 in Subjects With Moderate to Severe Ulcerative Colitis

Brief Summary: Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).This study will assess how safe and effective ABBV-668 is in treating adult participants with UC.Adverse events and change in disease activity will be assessed.ABBV-668 is an investigational drug being developed for the treatment of moderate to severe UC.Approximately 40 adult participants diagnosed with UC will be enrolled in approximately 23 sites…

Read more